Daybreak Deepinder Goyal built an app that fed Indians. With Temple, can he fix how they age?
23 snips
Mar 5, 2026 A startup built a wearable that measures blood flow in the brain and claims it can slow aging. The funding rush and a $190M valuation raise questions about investor pressure and who benefits. Skeptics point to missing peer review and shaky science while proponents tout novel devices and big market need in an aging country.
AI Snips
Chapters
Transcript
Episode notes
India Faces Rapid Aging And Rising Dementia
- India's population is rapidly aging and dementia cases could nearly double by 2036, creating urgent public-health pressure.
- A 2020 projection shows those aged 60+ may approach 20% by 2050 and dementia sufferers could rise from 8.8M to 17M by 2036.
Aging Research Is Structurally Underfunded
- Academic and government research on aging is underfunded and avoids speculative longevity work because outcomes take decades.
- Clinical trials for lifespan effects are slow and costly, so private money fills the vacuum despite long timelines.
Goyal Published A Hypothesis Before Peer Review
- Deepinder Goyal launched Continue Research, published the Gravity Aging Hypothesis on his website and Twitter, and then raised private capital for Temple.
- He raised roughly $54 million in a friends-and-family round and valued Temple at $19 million at announcement.